Metropolis Healthcare Ltd
Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.
- Market Cap ₹ 11,164 Cr.
- Current Price ₹ 2,184
- High / Low ₹ 2,323 / 993
- Stock P/E 88.6
- Book Value ₹ 120
- Dividend Yield 0.37 %
- ROCE 40.1 %
- ROE 30.6 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.96%
- Company has been maintaining a healthy dividend payout of 29.07%
Cons
- Stock is trading at 18.24 times its book value
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
176 | 193 | 190 | 202 | 203 | 223 | 223 | 207 | 143 | 288 | |
132 | 146 | 142 | 145 | 149 | 161 | 159 | 156 | 131 | 197 | |
Operating Profit | 44 | 47 | 49 | 57 | 55 | 62 | 64 | 51 | 12 | 91 |
OPM % | 25% | 25% | 26% | 28% | 27% | 28% | 29% | 25% | 8% | 32% |
Other Income | 2 | 5 | 2 | 1 | -5 | 2 | 2 | -15 | 3 | 3 |
Interest | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 |
Depreciation | 4 | 5 | 5 | 5 | 8 | 9 | 11 | 11 | 10 | 11 |
Profit before tax | 41 | 48 | 46 | 52 | 39 | 53 | 53 | 23 | 4 | 81 |
Tax % | 34% | 37% | 31% | 33% | 32% | 19% | 20% | 34% | 18% | 26% |
Net Profit | 27 | 30 | 31 | 34 | 27 | 43 | 42 | 15 | 3 | 60 |
EPS in Rs | 28.75 | 6.07 | 6.22 | 6.87 | 5.34 | 8.57 | 8.38 | 3.06 | 0.57 | 11.84 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|
388 | 456 | 475 | 545 | 647 | 761 | 856 | 861 | |
281 | 337 | 348 | 391 | 469 | 559 | 620 | 643 | |
Operating Profit | 107 | 119 | 127 | 154 | 178 | 203 | 236 | 218 |
OPM % | 28% | 26% | 27% | 28% | 28% | 27% | 28% | 25% |
Other Income | 7 | 5 | 18 | 26 | 8 | 8 | -16 | -6 |
Interest | 3 | 2 | 2 | 2 | 4 | 4 | 13 | 8 |
Depreciation | 16 | 21 | 17 | 17 | 19 | 20 | 39 | 43 |
Profit before tax | 95 | 101 | 128 | 160 | 164 | 187 | 169 | 161 |
Tax % | 34% | 33% | 36% | 33% | 32% | 34% | 24% | |
Net Profit | 57 | 61 | 77 | 102 | 104 | 120 | 127 | 121 |
EPS in Rs | 57.34 | 61.82 | 80.47 | 106.52 | 109.23 | 23.94 | 25.15 | 23.85 |
Dividend Payout % | 2% | -0% | 100% | 49% | -0% | 55% | 32% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 16% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 14% |
TTM: | -11% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 30% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 29% |
3 Years: | 30% |
Last Year: | 31% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|
10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Reserves | 292 | 352 | 269 | 314 | 405 | 408 | 513 | 602 |
Borrowings | 20 | 14 | 5 | 1 | 1 | 18 | 67 | 61 |
69 | 87 | 107 | 188 | 110 | 113 | 160 | 181 | |
Total Liabilities | 391 | 462 | 391 | 512 | 526 | 550 | 750 | 854 |
149 | 153 | 142 | 202 | 207 | 213 | 296 | 291 | |
CWIP | 1 | 0 | 1 | 1 | -0 | 6 | 3 | -0 |
Investments | 132 | 168 | 101 | 142 | 102 | 33 | 14 | 16 |
109 | 141 | 147 | 167 | 216 | 298 | 437 | 548 | |
Total Assets | 391 | 462 | 391 | 512 | 526 | 550 | 750 | 854 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|
77 | 69 | 91 | 102 | 104 | 90 | 215 | |
-61 | -56 | 96 | -86 | 1 | 36 | -104 | |
-14 | -9 | -174 | -17 | -87 | -118 | -55 | |
Net Cash Flow | 2 | 4 | 14 | -1 | 18 | 8 | 56 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|
ROCE % | 29% | 36% | 49% | 45% | 44% | 40% | |
Debtor Days | 47 | 57 | 54 | 54 | 57 | 66 | 55 |
Inventory Turnover | 8.37 | 7.83 | 9.71 | 8.83 | 7.80 | 8.58 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 20 Jan
- Business Update - Q3FY21 20 Jan
- Notice Of Postal Ballot 19 Jan
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 17 Jan
- Announcement under Regulation 30 (LODR)-Press Release / Media Release 17 Jan
View all